DMD is caused by the lack of Dystrophen which is the primary cause.
Last weeks announcement which is yet to be recognised by the market. $$
Atl1102 Re DMD fulfils the secondary target (Disease progression ) which is Inflation and Fibrosis..
In combination with the present DMD drugs it does add to the efficacy to a point .( which Sarepta and others are looking for )
By the end of this 1/4 we will have the results . Can Atl1102 generate Dystrophen
Just a sniff of a positive result will send our Sp to 35c..( Game Changer)
Keep the Faith:
We Wait.
Atl1102 a Game Changer for DMD
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
-0.001(1.27%) |
Mkt cap ! $80.86M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.7¢ | $374.4K | 4.803M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 308385 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 818650 | 4 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |